FDA Inspection 1108753 — Dipharma Francis S.R.L.
The FDA completed an inspection of Dipharma Francis S.R.L. on Sep 13, 2019 in Baranzate. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Sep 13, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Baranzate (Italy)